DrugPatentWatch Database Preview
Hydrocortisone sodium succinate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for hydrocortisone sodium succinate and what is the scope of freedom to operate?
Hydrocortisone sodium succinate
is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Abraxis Pharm, Baxter Hlthcare, Intl Medication, Watson Labs, and Pharmacia And Upjohn, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.There are sixty-seven drug master file entries for hydrocortisone sodium succinate. Three suppliers are listed for this compound.
Summary for hydrocortisone sodium succinate
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 7 |
| NDAs: | 25 |
| Drug Master File Entries: | 67 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 30 |
| Clinical Trials: | 11 |
| Patent Applications: | 1,450 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in hydrocortisone sodium succinate? | hydrocortisone sodium succinate excipients list |
| DailyMed Link: | hydrocortisone sodium succinate at DailyMed |
Recent Clinical Trials for hydrocortisone sodium succinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Instituto do Coracao | Phase 3 |
| IMSS Hospital General de Zona 11, Piedras Negras | Phase 3 |
| Emory University | Phase 3 |
Pharmacology for hydrocortisone sodium succinate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for hydrocortisone sodium succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | A-HYDROCORT | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 085932-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 084738-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Abraxis Pharm | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 088667-001 | Jun 8, 1984 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
